Jupiter Neurosciences, Inc.
General ticker "JUNS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $26.4M (TTM average)
Jupiter Neurosciences, Inc. does not follow the US Stock Market performance with the rate: -27.9%.
Estimated limits based on current volatility of 4.7%: low 2.68$, high 3.08$
Factors to consider:
- Total employees count: 5 (-50.0%) as of 2025
- Top business risk factors: Liquidity and credit risks, Operational and conduct risks, Unable to continue as going concern, Need additional capital, Limited stock trading volume
- Current price 93.2% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [39.10$, 140.08$]
- 2026-12-31 to 2027-12-31 estimated range: [19.30$, 76.57$]
Short-term JUNS quotes
Long-term JUNS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.02MM |
| Operating Expenses | $3.87MM | $3.09MM | $8.93MM |
| Operating Income | $-3.87MM | $-3.09MM | $-8.91MM |
| Non-Operating Income | $-0.91MM | $0.65MM | $0.26MM |
| Interest Expense | $0.22MM | $0.25MM | $0.07MM |
| R&D Expense | $0.95MM | $0.49MM | $2.09MM |
| Income(Loss) | $-4.78MM | $-2.44MM | $-8.64MM |
| Net Income(Loss)* | $-4.78MM | $-2.44MM | $-8.64MM |
| Stockholders Equity | $-5.80MM | $4.17MM | $-1.83MM |
| Inventory | $0.00MM | $0.00MM | $0.16MM |
| Assets | $0.15MM | $6.20MM | $5.56MM |
| Operating Cash Flow | $-0.48MM | $-3.91MM | $-5.41MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $0.45MM | $7.65MM | $5.43MM |
| Earnings Per Share** | $-10.91 | $-6.36 | $-18.72 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.